🔎 Trials Near Me

Pradžia › Opinis kolitas › Ilinoisas

Opinis kolitas klinikiniai tyrimai Ilinoisas

24 tyrimai dėl Opinis kolitas ieško dalyvių vietose Ilinoisas.

Miestai Ilinoisas

Oficialus tyrimo tekstas (anglų kalba)

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

  • Midwest Digestive Health & Nutrition /ID# 285250, Des Plaines
  • Gi Alliance - Glenview /ID# 283932, Glenview
  • Illinois Gastroenterology Group /ID# 283933, Gurnee
  • ir dar 1
Renkami dalyviai2 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-10-02 · NCT07697456

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

  • Yapp, Rockford M.D. (Private Practice), Downers Grove
  • GI Alliance - Glenview, Glenview
  • Gastroenterology and Internal Medicine Specialists, SC, Lake Barrington
  • ir dar 3
Renkami dalyviai4 fazė
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-09-30 · NCT06581328

A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis

  • University of Chicago Medical Center /ID# 271588, Chicago
Renkami dalyviai3 fazė
Amžius nuo 2 iki 17 · Visoms lytims · Atnaujinta 2026-09-30 · NCT07071519

A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis

  • Northwestern University, Chicago
  • Avicenna Clinical Research - SW Gastroenterology, Oak Lawn
Renkami dalyviai2 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-09-30 · NCT06598943

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

  • Site 038, Chicago
Renkami dalyviai2 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-09-29 · NCT07012395

A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis

  • Site US-005, Des Plaines
  • Site US-007, Glenview
  • Site US-020, Gurnee
Renkami dalyviai2 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-09-29 · NCT07845487

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)

  • University of Chicago Medical Center, Chicago
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-28 · NCT06979336

A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis

  • Local Institution - 0101, Park Ridge
Renkami dalyviai2/3 fazė
Amžius nuo 2 iki 17 · Visoms lytims · Atnaujinta 2026-09-24 · NCT05076175

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

  • Rush University Medical Center, Chicago
Renkami dalyviai3 fazė
Amžius nuo 18 iki 70 · Visoms lytims · Atnaujinta 2026-09-24 · NCT06937086

LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:

  • Center for Gastrointestinal Health - Fairview Heights, Belleville
  • Northwestern University, Chicago
  • Midtown Gastroenterology and Liver Disease, Des Plaines
  • ir dar 2
Renkami dalyviai2 fazė
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-09-22 · NCT07186101

A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease

  • Rush University Medical Center, Chicago
Renkami dalyviai2 fazė
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-09-22 · NCT07483073

LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis

  • Northwestern University, Chicago
  • Rush University Medical Center, Chicago
  • Midwest Digestive Health & Nutrition, Des Plaines
  • ir dar 1
Renkami dalyviai2 fazė
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-09-22 · NCT07415044

A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

  • University of Chicago Medicine, Chicago
Renkami dalyviai4 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-09-21 · NCT06095128

A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis

  • Illinois Gastroenterology Group - Gurnee, Gurnee
Renkami dalyviai2 fazė
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-08-21 · NCT06636656

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

  • Rush University Medical Center - Site Number: 8400015, Chicago
  • Midwest Digestive Health and Nutrition - Site Number: 8400136, Des Plaines
  • GI Alliance - Glenview - Site Number: 8400068, Glenview
  • ir dar 1
Renkami dalyviai3 fazė
Amžius nuo 16 iki 80 · Visoms lytims · Atnaujinta 2026-08-20 · NCT07184996

Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

  • University of Chicago Medicine, Chicago
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-07 · NCT05230173

An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis

  • Feinberg School of Medicine Northwestern University, Chicago
  • Rush University Medical Center, Chicago
  • Suburban Gastroenterology Ltd, Naperville
Renkami dalyviaiStebimasis tyrimas
Amžius nuo 18 iki 64 · Visoms lytims · Atnaujinta 2026-07-09 · NCT06398626

A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis

  • University of Chicago Medical Center, Chicago
Renkami dalyviai2 fazė
Amžius nuo 12 iki 17 · Visoms lytims · Atnaujinta 2026-07-08 · NCT05287126

A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)

  • Advocate Children's Hospital Park Ridge, Park Ridge
Renkami dalyviai3 fazė
Amžius nuo 2 iki 17 · Visoms lytims · Atnaujinta 2026-06-22 · NCT06405087

Selenium Supplementation in Moderate-Severely Active Ulcerative Colitis Patients Treated With Advanced Therapies

  • Northwestern University, Chicago
Renkami dalyviai2 fazė
Amžius nuo 18 iki 85 · Visoms lytims · Atnaujinta 2026-05-22 · NCT07427017

A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)

  • Advocate Children's Hospital - Park Ridge - PIN, Park Ridge
Renkami dalyviai3 fazė
Amžius 2 ir vyresni · Visoms lytims · Atnaujinta 2026-05-07 · NCT05442567

STOP-UC: De-escalation of Therapy in Patients With Ulcerative Colitis With Histological Remission

  • University of Chicago, Chicago
Renkami dalyviai
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-04-06 · NCT06693310

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

  • Mirador Therapeutics Selected Site, Glenview
  • Mirador Therapeutics Selected Site, Gurnee
Renkami dalyviai2 fazė
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-03-12 · NCT07113522

Hyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC)

  • Northwestern Medicine Lake Forest Hospital, Lake Forest
Renkami dalyviai
Amžius nuo 18 iki 85 · Visoms lytims · Atnaujinta 2026-01-08 · NCT05987852

Iš ClinicalTrials.gov, duomenys gauti 2026-10-04. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.